The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Cardiovasc. Med.
Sec. Cardiac Rhythmology
Volume 11 - 2024 |
doi: 10.3389/fcvm.2024.1448523
Concomitant ablation for non-paroxysmal atrial fibrillation: combined energy versus cryoablation alone
Provisionally accepted- 1 Meshalkin National Medical Research Center, Novosibirsk, Russia
- 2 Sobolev Institute of Mathematics (RAS), Novosibirsk, Novosibirsk Oblast, Russia
- 3 Guy's and St Thomas' NHS Foundation Trust, London, London, United Kingdom
Surgical ablation of atrial fibrillation has been the most efficient treatment for atrial fibrillation (AF). Combined energy (CE) ablation and cryoablation alone (CA) are the most common energy modes used for ablation, however, comparative data is lacking. lower cumulative incidence of stroke (SHR=0.38, 95% CI 0.15-0.97, p=0.043). No significant difference in permanent pacemaker implantation was observed between the two groups.In the setting of concomitant biatrial ablation for non-paroxysmal AF, combined bipolar radiofrequency and cryoablation appear to be a superior treatment modality compared to cryoablation alone in achieving long-term freedom from atrial arrhythmias, in reducing arrhythmia-related hospital readmissions and ischemic strokes.
Keywords: Atrial Fibrillation, Maze procedure, Biatrial ablation, concomitant ablation, Radiofrequency ablation, Cryoablation
Received: 13 Jun 2024; Accepted: 03 Sep 2024.
Copyright: © 2024 Tsaroev, Sharifulin, Afanasyev, Khrushchev, Murtazaliev, Lovtsova, Kashapov, Ruzankin, Mustaev and Bogachev-Prokophiev. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Bashir Tsaroev, Meshalkin National Medical Research Center, Novosibirsk, Russia
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.